Tower Research Capital (TRC)’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History
Bought
Maintained
Sold
Other funds holding CRCD
SG
TSS
Tower Research Capital (TRC)'s CRCD Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its T-REX 2X Inverse CRCL Daily Target ETF (CRCD) stake by 12% in Q1 2026, selling an estimated $384 and leaving 100 shares worth $675. The position accounts for ﹤0.01% of the portfolio, ranked #4800.
Tower Research Capital (TRC) first reported a position in CRCD in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.92K in Q4 2025. 8 funds tracked by Wall St. Rank hold CRCD as of Q1 2026.
- Tower Research Capital (TRC) held 100 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $675 as of Q1 2026.
- Tower Research Capital (TRC) sold 14 T-REX 2X Inverse CRCL Daily Target ETF shares in Q1 2026, an estimated $384.
- T-REX 2X Inverse CRCL Daily Target ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4800 holding.
- Tower Research Capital (TRC) first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q4 2025 and has held it in 2 quarters since.
- Tower Research Capital (TRC)'s T-REX 2X Inverse CRCL Daily Target ETF position peaked at $3.92K in Q4 2025.
- 8 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.